Katherine Stueland, Chief Commercial Officer at Invitae, provides an overview of her company and their attendance at this year’s 8th Orphan Drugs and Rare Diseases conference in Boston, MA in September.
Invitae is a genetic information company bringing genetic information into mainstream medical practice. Invitae utilizes an integrated portfolio of laboratory processes, software tools, and informatics capabilities to process DNA-containing samples, analyze information about patient-specific genetic variation, and generate test reports for clinicians and their patients. Invitae provides a variety of diagnostic tests with clinical utility in:
– Preimplantation and carrier screening for inherited disorders
– Miscarriage analysis
– Pediatric and developmental disorders
– Neurological disorders
– Cardiovascular disorders
– Metabolic disorders
– Hereditary cancer